It is FDA-indicated for three main uses: Cardiovascular Risk Reduction (In a Specific Group) To reduce the risk of major adverse cardiovascular events such as cardiovascular death, non-fatal heart attack, or non-fatal stroke in adults with established cardiovascular disease who also have obesity or are overweight
Table of Contents Comparison Table: Tirzepatide vs Semaglutide at a Glance Clinical Effectiveness: What the Research Shows
Focus on a nutrient-dense, plant-forward plate: roughly half fruit and vegetables, 2530% protein-rich foods such as legumes, tofu, and tempeh, and 2025% whole-grain carbohydrates, plus small amounts of healthy fats like olive oil, flax, and walnuts
Keeping the Weight Off After Menopause Weight Loss Because appetite returns if a GLP-1 is reduced or stopped, the maintenance plan is as important as the weight loss itself, and it should be built from the start rather than scrambled together at the end